Acquity Premier, a liquid chromatography (LC) solution that utilizes MaxPeak high-performance surface technology, was introduced by Waters in February 2021. Acquity Premier is a universal liquid chromatography solution that integrates the Acquity Premier system with Acquity Premier columns. It is intended to resolve issues with analyte/metal surface interactions in the context of the analysis of organic acids, organophosphates, oligonucleotides, phosphopeptides, acidic glycans, and phospholipids using reversed-phase and hydrophilic interaction chromatography.
The Acquity Premier columns are equipped with MaxPeak high-performance surface technology, which erects a barrier between the metal surface of the system and the column and the samples. The nonspecific adsorption is either wholly eliminated or mitigated by the technology. It is intended to resolve the issue of analyte/metal surface interactions in the analysis of organic acids, organophosphates, oligonucleotides, phosphopeptides, acidic glycans, and phospholipids through reversed phase and hydrophilic interaction chromatography. The new ACQUITY PREMIER solution for these analyses reduces the time from sample to results, enhances analyte recovery, and improves assay-to-assay reproducibility. This provides separation scientists with greater confidence in the integrity of their qualitative and quantitative analytical results.
Tosoh Bioscience LLC, a provider of chromatographic solutions for the separation and purification of biomolecules, has announced the introduction of SkillPak 1 mL and 5 mL pre-packed columns in March 2020. These process development columns are intended for the rapid development of methods and the resin screening of monoclonal antibodies, antibody constructs, oligonucleotides, proteins, and viruses. SkillPak 1 mL and 5 mL columns are pre-packed with TOYOPEARL®, TSKgel®, or Ca++Pure-HA™ process chromatography media, providing customers with increased flexibility for the use of process media from Tosoh.
As a result, they deliver high performance and offer scalability and convenience. Upon receipt, these columns are prepared for use and exhibit exceptional physical strength, as well as optimal flow characteristics specifically designed for industrial downstream processing. In the chromatographic modes of affinity, anion and cation exchange, hydrophobic interaction, and size exclusion, SkillPak 1 mL and 5 mL pre-packed columns are currently available with short delivery periods. The columns are designed to provide optimal performance and can be directly operated with low or medium pressure liquid chromatography systems that are frequently employed.
The hydrophobic interaction chromatography market has been segmented into product and service, sample type, and end-user.
The market, on the basis of products and services, has been segmented into products such as resins, columns, HIC columns, buffers, and other products and services. The resins segment has been segmented into bead-based resins and membrane-based resins. The column segment has been further segmented into empty columns and pre-packed columns.
HIC columns on the basis of material are further segmented into stainless steel columns and glass and plastic columns.
The market, by sample type, has been segmented into monoclonal antibodies, vaccines, and others.
The market, by end-user, has been segmented into pharmaceutical and biopharmaceutical companies, contract research organizations and contract manufacturing organizations, research and academic institutes, and others.
Geographically, the hydrophobic interaction chromatography market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The American hydrophobic interaction chromatography market is further segmented into North America and South America. North America is further classified as the US and Canada.
The European hydrophobic interaction chromatography market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe.
The Asia-Pacific hydrophobic interaction chromatography market is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific.
The Middle Eastern and African hydrophobic interaction chromatography market is segmented into the Middle East and Africa.
The hydrophobic interaction chromatography market consists of four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is expected to dominate the hydrophobic interaction chromatography market owing to the presence of government and public funding for protein-based research projects, rising automation of purification equipment, and growing demand for protein-based biologics. Additionally, the increasing research and development expenditure is expected to contribute to the market growth in the region. According to the UNESCO Institutes for Statistics, in the US, the research & development expenditure was 2.79% of the GDP (Gross Domestic Product) in 2015.
Europe is anticipated to hold the second largest position in the hydrophobic interaction chromatography market. It is expected that the increasing funding provided by the government and private organizations towards research and development is anticipated to drive the European market.
The Asia-Pacific hydrophobic interaction chromatography market consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. Asia-Pacific is expected to be the fastest growing region in the hydrophobic interaction chromatography market. Major factors such as a growing number of contract research organizations, developing healthcare infrastructure, increasing research and development activities in the biotechnology sector and increasing healthcare expenditure influence the market in this region.
The Middle East and Africa holds the least share in the hydrophobic interaction chromatography market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.
Recent Development
Some of the key players in the global hydrophobic interaction chromatography market are:
Hydrophobic Interaction Chromatography Market, by Product and Service
Hydrophobic Interaction Chromatography Market, by Sample Type
Hydrophobic Interaction Chromatography Market, by End-User
Hydrophobic Interaction Chromatography Market, by Region
| Report Attribute/Metric | Details |
| Â Â Market Size | Â 0.44 Billion |
| Â Â CAGR | Â Â 7.7% (2023-2032) |
| Â Â Base Year | Â Â 2021 |
| Â Â Forecast Period | Â Â 2023-2032 |
| Â Â Historical Data | Â Â 2018 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Product and Service, Sample Type, and End-user |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Bio-Rad Laboratories, Sartorius AG, Thermo Fisher Scientific, GE Healthcare, Tosoh Corporation, Waters Corporation, Geno Technology, Sepax Technologies, JNC Corporation, Agilent Technologies, Merck KGaA, Mitsubishi Chemical Corporation, Danaher Corporation, and Avantor Performance Materials |
| Â Â Key Market Opportunities | Â Â Increasing number of contract research organizations and contract manufacturing organizations |
|   Key Market Drivers | · Rising demand for monoclonal antibodies· Increasing research and development expenditure in biopharmaceuticals |
Frequently Asked Questions (FAQ) :
Hydrophobic Interaction Chromatography Market is projected to grow at a 7.7% CAGR between 2023-2032.
The Americas is expected to lead the Hydrophobic Interaction Chromatography Market.
Different end use industries of hydrophobic interaction chromatography include research & academic institutes, biopharmaceutical & pharmaceutical companies, and others.
Increasing expenditure in biopharmaceuticals and demand for monoclonal antibodies are adding market growth.
Lack of skilled labor may limit market growth.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
